This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

Text Version  RSS  Subscribe  Unsubscribe  Archive  Media Kit May 08, 2015
Home    About AST    Education    Meetings & Events    Public Policy    Contact Us  



Thanks for a great ATC 2015!
The 2015 American Transplant Congress (ATC) wrapped up this past Wednesday, May 6. This year's ATC featured a multitude of programs designed for all professionals interested in solid organ and tissue transplantation. Throughout the five-day event, groundbreaking research was presented that challenged and stretched the scientific and clinical knowledge of transplant professionals worldwide.

Approximately 1,700 abstracts, 530 concurrent oral sessions, and 2,000 poster presentations were delivered in a way that encouraged the exchange of new information and supported an interchange of opinions regarding care management as well as socioeconomic, ethical, and regulatory issues relevant to organ and tissue transplantation. The event also provided multiple opportunities for networking, from the AST Town Hall to ATC's Night Out. We're already looking forward to next year!
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

ATC 2016 Program submission available
The 2016 American Transplant Congress Program Planning Committee is now accepting program proposals for scientific sessions to be held June 11-15, 2016 in Boston, Massachusetts. Participate in the Call for Programs and share your experience and knowledge with leaders in the transplantation community from across the globe. The deadline to submit proposals is June 5, 2015
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

QAPI Webinar: Objective Measures – Monitoring & Evaluating Services
Join us and ASTS on Wednesday, May 13 at Noon ET for the third installment of a monthly webinar series designed and presented by the Centers for Medicare and Medicaid Services. This webinar will offer an insightful look into developing objective measures that allow monitoring and evaluation of transplantation activities in order to improve outcomes. Register today!

The content of this presentation is determined independently by CMS without input or endorsement from either the ASTS or AST. Both societies appreciate CMS providing this information to the transplant community and are pleased to facilitate that process.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

You care about your transplant patients. And so do we. That’s why we’re introducing Astellas Cares—a new program that offers you customized tools, educational resources, and comprehensive support to help your patients care for their health. To register, visit today.

Update on Hepatitis C eradication: Webinar, May 19
Register today for the final webinar in AST's 2014-2015 Timely Topics in Transplantation series, "Update on Hepatitis C Eradication Including Renal Clearance and Dosing and Important DDI Highlights." Presented by Kimberly Brown, M.D. and Tiffany Kaiser, PharmD, this webinar focuses on emerging therapies for HCV in transplant patients with specific attention to drug-drug interactions and limitations in patients with renal disease.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

  UCLA Immunogenetics Center

The UCLA Immunogenetics Center (UIC) provides comprehensive testing for organ and tissue transplantation. Transplant testing has a long history at UCLA. HLA typing was pioneered here in the 1960's. The development of the microcytoxicity test in 1964 marked the beginning of international testing and standardization of HLA typing. The UCLA Immunogenetics Center has retained its leadership position in HLA research, and in the development of accompanying diagnostic testing. MORE


Role of patient factors and practice patterns in determining access to liver waitlist
American Journal of Transplantation
Geographic variability in access to care is a persistent challenge in transplantation. Little is known about how patients with end-stage liver disease are chosen for referral, evaluation and listing. Utilizing death certificate data from the Centers for Disease Control and Prevention from 2002 to 2009, estimated liver demand (ELD) was measured by aggregating annual deaths from liver disease and liver transplants performed in each donor service area (DSA).
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

  Missing or Broken Doppler Probes?

VTI’s disposable intraoperative Doppler probes are ready to verify technical results. There’s no longer the need to perform sterilization that frequently causes irreversible damage to the traditional Doppler probes. Advantages include fewer replacements of conventional Doppler probes damaged during sterilization, OR time saved, and a reduction in specialty procedures.

Diagnosis and treatment of Clostridium difficile in adults
Since 2000, the incidence and severity of Clostridium difficile infection (CDI) have increased. The aim of this study was to review current evidence regarding best practices for the diagnosis and treatment of CDI in adults (age ≥18 years). Ovid MEDLINE and Cochrane databases were searched using keywords relevant to the diagnosis and treatment of CDI in adults. Articles published between January 1978 and Oct. 31, 2014, were selected for inclusion based on targeted keyword searches, manual review of bibliographies, and whether the article was a guideline, systematic review, or meta-analysis published within the past 10 years.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

A multicenter analysis of clinical hemolysis in patients supported with durable, long-term left ventricular assist device therapy
The Journal of Heart and Lung Transplantation
Despite the beneficial effects of mechanical circulatory support (MCS), the majority of patients ultimately will have an adverse event. Although hemolysis is common among temporary devices, the incidence and clinical significance of hemolysis in patients managed with long-term, durable left ventricular assist device (LVAD) therapy is largely unknown.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Raptor's mission is to develop and commercialize life-altering therapeutics that treat rare, debilitating, and often fatal diseases.
Advertise here!

To find out how to feature your company in the AST eNewsletter and other advertising opportunities, Contact Tom Crist at 972-402-7724.

Clinical characteristics of HIV patients being referred for liver transplant evaluation: A descriptive cohort study
Transplant Infectious Disease
Liver transplantation (LT) is a treatment option for select human immunodeficiency virus (HIV)-infected patients with advanced liver disease. The aim of this study was to describe LT evaluation outcomes in HIV-infected patients. All HIV-infected patients referred for their first LT evaluation at the Mount Sinai Medical Center were included in this retrospective, descriptive cohort study. Multivariable logistic regression was used to identify factors independently associated with listing.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Critical factors associated with missing follow-up data for living kidney donors in the United States
American Journal of Transplantation
Follow-up care for living kidney donors is an important responsibility of the transplant community. Prior reports indicate incomplete donor follow-up information, which may reflect both donor and transplant center factors. New UNOS regulations require reporting of donor follow-up information by centers for 2 years. We utilized national SRTR data to evaluate donor and center-level factors associated with completed follow-up for donors 2008–2012 (n = 30 026) using multivariable hierarchical logistic models.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Missed last week's issue? See which articles your colleagues read most.

    Should HLA mismatch acceptability for sensitized transplant candidates be determined at the high-resolution rather than the antigen level? (American Journal of Transplantation)
Lung transplant waitlist mortality: Height as a predictor of poor outcomes (Pediatric Transplantation)
Lung transplantation with donation after circulatory determination of death donors and the impact of ex vivo lung perfusion (American Journal of Transplantation)
Prognostic implications of serial risk score assessments in patients with pulmonary arterial hypertension: A Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) analysis (The Journal of Heart and Lung Transplantation)

Don't be left behind. Click here to see what else you missed.

AST eNews

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Julie Bernhard, Executive Editor, 469.420.2647  
Contribute news

This edition of the AST eNews was sent to ##Email##. To unsubscribe, click here.

Recent issues
May 1, 2015
April 24, 2015
April 17, 2015
April 10, 2015


7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063